Company / CapEx per Share
Idexx Laboratories CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$1.53
FY2025
5-year range
$1.40 / $1.76
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#41 of 142
Health Care
What the data says
At $1.53, Idexx Laboratories's capex per share ranks #41 of 142 in the Health Care sector. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $1.53.
Based on SEC 10-K filings.
1.53 in FY2025 with a 5-year CAGR of +4.1%.
Declined from $1.61 to $1.53 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Sector benchmark
#41 of 142 in Health CareTop 29% of 142This company $1.53 Sector average $1.70
▼
-10.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 4.9% year-over-year.
- Ranks #41 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.53 | +4.9% |
| FY2024 | $1.46 | -9.7% |
| FY2023 | $1.61 | -8.4% |
| FY2022 | $1.76 | +25.8% |
| FY2021 | $1.40 | +11.8% |
| FY2020 | $1.25 | -30.5% |
| FY2019 | $1.80 | +35.4% |
| FY2018 | $1.33 | +67.3% |
| FY2017 | $0.79 | +24.4% |
| FY2016 | $0.64 | -16.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026